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Introduction: There are many established environmental toxins that correlate with urothelial cancer.
Genetic variations in phosphoinositide-3 kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR)
pathway have also been reported to have association with the risk of urothelial cancer and clinical
outcome. The aim of this study is to validate the role of the established RAPTOR gene carrying the risk of
urothelial cancer compared with environmental toxin exposure.
Methods: This study included 168 patients with urothelial cancer and 168 patients with voiding problem
as normal control. All these patients were above 50 years old. Environmental toxin exposure such as
smoking, arsenic, and Chinese herb were deﬁned as regular exposure in usual life. RAPTOR single
nucleotide polymorphisms (SNPs) were analyzed by HardyeWeinberg equilibrium to compare the
observed genotype frequencies to the expected genotype frequencies in controls. Pearson's c2 test was
used to compare the difference in distribution of categorical variables. Statistical signiﬁcance was set if p
value less than 0.005 in this study.
Results: RAPTOR gene polymorphisms (rs11653499 and rs7212142) were revealed to be signiﬁcantly
associated to the risk of urothelial cancer whether the patients is under environmental toxin exposure or
not (both p < 0.001). The predictive effects of urothelial cancer for these two SNPs were both inde-
pendently signiﬁcant by multivariate analysis (p < 0.001).
Conclusion: RAPTOR gene polymorphisms are important SNPs with signiﬁcantly association with the risk
of urothelial cancer in Taiwan. Further researches about raptor-mTOR complex interfering malignant
transformation of urothelium is worthy of further investigation.
Copyright © 2016, Taiwan Urological Association. Published by Elsevier Taiwan LLC. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Urothelial cancer includes urinary bladder and upper urinary
tract urothelial carcinoma. There are many established environ-
mental toxins, such as smoking, arsenic exposure, and herb expo-
sure, that correlate with urothelial cancer.1 The history of
environmental toxin exposure is regularly taken in our clinical
practice. However, the prevalence of urothelial carcinoma is still
high in the Taiwanese population. Genetic characteristics in they, Kaohsiung Chang Gung
siung 83301, Taiwan.
hiang).
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iations in the phosphoinositide-3 kinase (PI3K)-AKT-mammalian
target of rapamycin (mTOR) pathway have also been reported to
have an association with the risk of urothelial cancer and clinical
outcome.2,3 The mTOR inhibitor was also found to inhibit growth of
bladder cancer cells.4 However, the effect of urothelial cancer sus-
ceptibility has not been compared between environmental toxins
and RAPTOR genetic variations. Identifying whether genetic or
environmental factors are more signiﬁcant predictors of urothelial
cancer helps in developing cancer-screening programs using sim-
ple parameters. Therefore, the aim of this study is to validate the
role of the established RAPTOR gene carrying the risk of urothelial
cancer compared with environmental toxin exposure.iwan LLC. This is an open access article under the CC BY-NC-ND license (http://
ism is independently correlated with urothelial cancer susceptibility
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Table 2
Distribution of genetic variation according to environmental toxin exposure.
Environmental toxin (þ) Environmental toxin (e)
UCC (þ) UCC (e) p UCC (þ) UCC (e) p
rs7211818 W 45 58 0.393 50 41 0.773
V 41 41 31 28
rs7212142 W 3 48 < 0.001 1 14 < 0.001
V 83 51 81 55
rs9674559 W 26 36 0.378 34 34 0.371
V 60 63 35 47
rs11653499 W 48 92 < 0.001 40 53 < 0.001
V 37 6 42 16
UCC¼ urothelial cell carcinoma; V¼ variant type; W¼wild type.
Table 3
Multivariate analysis for urothelial cancer susceptibility.
Univariate
p
Multivariate
p
rs7212142
Variant vs. wild
< 0.001 < 0.001
HR¼ 17.0
95%CI¼ 5.76e50.21
rs11653499
Variant vs. wild
< 0.001 < 0.001
HR¼ 3.63
95%CI¼ 2.03e6.50
rs7211818 0.300
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2.1. Patient and DNA sample collection
Urothelial cancer is relatively common in the elderly5; therefore,
this study included patients older than 50 years. There were 168
patients with urothelial cancer and 168 normal controls in this
hospital caseecontrol study. Environmental toxin exposure such as
via cigarette smoking, Chinese herbal remedies, and arsenic expo-
sure was recorded by questionnaire. Regular exposure to daily
cigarette smoking of duration > 5 years from our visit date, herb
intake of interval < 3 months and duration > 5 years from our visit
date, and history of living in an area of black foot disease with
underground water intake history were deﬁned as positive envi-
ronmental toxin exposure. This study was approved by the Insti-
tutional Review Board of the Kaohsiung Chang Gung Medical
Center, Kaohsiung, Taiwan. Informed consent was obtained from
each participant, and they donated about 10 mL of blood for single
nucleotide polymorphism (SNP) analysis. Genomic DNA samples
were isolated using the phenolechloroform method. Genotyping
was performed using the TaqMan Allelic Discrimination Assay
(Applied Biosystems, Foster City, CA, USA) with commercially
available primer probes for rs11653499, rs7211818, rs7212142, and
rs9674559. Polymerase chain reaction was carried out using the
ABI7900 (Applied Biosystems, San Diego) Thermal Cycler. After
polymerase chain reaction, ﬂuorescence from reaction products
was measured and analyzed using the System SDS (Thermo Fisher
Scientiﬁc Inc., San Diego) software version 2.4.
2.2. Statistical analysis
The environmental toxin exposure in both groups was analyzed
by c2 test. HardyeWeinberg equilibrium (HWE) of the genotype
was examined by performing a goodness-of-ﬁt c2 test. The allele
distribution was consistent with HWE if p> 0.05. Multivariate
analysis with log rank test was used to identify the independent
role of predictive factors for urothelial cancer. Statistical signiﬁ-
cance was set at p< 0.05.
3. Results
The present study included 168 patients with urothelial cancer
and 168 normal controls. The patient demography is listed in
Table 1. The allele distributions were consistent with the HWE
(c2¼ 2.5, p¼ 0.11 for rs11653499; c2¼ 0.002, p¼ 0.95 for
rs7211818; c2¼ 2.9, p¼ 0.08 for rs7212142; and c2¼ 0.23, p¼ 0.63
for rs9674559).
This study analyzed the genotype by dominant model and
observed the association between genotype and urothelial cancer
in consideration of environmental toxin exposure. Table 2 reveals
that RAPTOR genetic variations in rs7212142 and rs11653499 wereTable 1
Patient demography.
UC (þ), n¼ 168 UC (e), n¼ 168 p
Age 69.9± 9.0 67.9± 10.2 0.06
Sex (M/F) 111/57 116/36 0.01
Smoker 23 25 0.755
Possible arsenic exposure 23 8 0.005
Regular herb exposure 88 67 0.022
Cancer location
UUT involvement 37
UB involvement 100
UUT and UB involvement 31
UB¼ urinary bladder; UC¼ urothelial carcinoma; UUT¼ upper urinary tract.
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p< 0.001), with or without environmental toxin exposure. This
study further analyzed the impact of genetic variation in suscep-
tibility for urothelial cancer by logistic multivariate analysis
(Table 3). The RAPTOR genes, rs7212142 and rs11653499, were both
independently associated with urothelial cancer (both p< 0.001)
and the predictive effect of RAPTOR genetic variations was more
prominent than sex, age, or environmental toxin exposure.4. Discussion
Urothelial cancer including urinary bladder and upper urinary
tract urothelial carcinoma is common in Taiwan and worldwide.5,6
Advanced urothelial cancer is often associated with a high mor-
tality rate. An effective urothelial cancer-screening program for
signiﬁcant cancer-predictive factors helps early detection and
lowers the cancer-speciﬁc mortality. The etiology of urothelial
cancer is complex and attributed to environmental or genetic
factors. Established environmental toxins such as smoking, Chi-
nese medicine herbs, and arsenic exposure increased the risk of
urothelial carcinoma.1 In addition, RAPTOR SNPs are also reported
to increase the risk of urothelial carcinoma.2 It is unknown
whether environmental or genetic factors play the more impor-
tant role in susceptibility of urothelial cancer. Comparing theVariant vs. wild
rs9674559
Variant vs. wild
0.699
Age
> 70 y vs.  70 y
0.062
Sex
Male vs. female
0.010 0.021
HR¼ 2.207
95%CI¼ 1.11e3.70
Former smoker
Yes vs. no
0.047 0.074
Arsenic exposure
Yes vs. no.
0.002 0.019
HR¼ 3.38
95%CI¼ 1.22e9.38
Chinese herb exposure
Yes vs. no.
0.047 0.307
CI¼ conﬁdence interval, HR¼ hazard ratio.
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cancer screening.
Smoking is generally thought to be associated with suscepti-
bility and outcome of urothelial cancer.7 However, the prognostic
effect of smoking for urothelial cancer was not independent in our
experience,8 and the smoking-related susceptibility to urothelial
cancer is based on transcriptional change of oncogenes. Such evi-
dence supported that smoking might not be an independent pre-
dictive factor of urothelial cancer but possibly shares a joint effect
with genetic variation.9 Arsenic exposure and subsequent black
foot disease and Chinese herb nephropathy are also well-known
environmental risk factors related to urothelial cancer occur-
rence.10,11 However, there is a relatively low percentage of urothe-
lial cancer patients with such environmental toxins in our single
institutional experience. The theory of environmental toxin-related
urothelial cancer was not enough to explain the high prevalence in
Taiwanese populations. Therefore, it is reasonable to explore more
predictive targets to enhance cancer screening.
The relationship between the PI3K-AKT-mTOR pathway and
cancer has been revealed in several malignancies.12e14 Raptor is a
scaffold protein interacting with mTOR, a eukaryotic translation
initiating factor 4E binding protein 1 and ribosomal protein kinase
activation.2 Chen et al2 comprehensively reviewed the genetic
variations in the PI3K-AKT-mTOR pathway and identiﬁed four SNPs
(rs11653499, rs7211818, rs7212142, and rs9674559) associated
with bladder cancer susceptibility. Although the function of raptor
and tumorigenesis is not clear, the mTOR pathway is important and
associated with cell proliferation and cell instability. The effect of
scaffold protein needs more validation study about its carcino-
genesis potential. Therefore, this study analyzed the currently
known RAPTOR SNPs carrying the risk of urothelial cancer in a
hospital caseecontrol series and compared the cancer predictive
effect between RAPTOR genetic variation and environmental toxins.
In this study, patients with RAPTOR genetic variation (rs7212142
and rs11653499) had higher incidence of urothelial carcinomawith
or without environmental toxin exposure. Finally, the multivariate
analysis revealed the independent role of these two RAPTOR genetic
variations (p< 0.001) in susceptibility of urothelial cancer. The
predictive effect of RAPTOR SNPs is more prominent than envi-
ronmental toxins such as smoking, Chinese herbs, and arsenic
exposure.
The limitation of this study is its relatively small case number.
However, the genetic variations were similarly distributed in both
groups. The statistical signiﬁcance was still prominent under
multivariate analysis in consideration of currently known envi-
ronmental risk factors. In this study, the genetic factors were more
important than the environmental factors in our observation. This
ﬁnding would help development of cancer screening programs in
public health issues. Further external validation is still necessary to
validate our ﬁnding.Please cite this article in press as: Luo HL, et al., RAPTOR gene polymorph
compared with environmental toxin exposure, Urological Science (2016)5. Conclusion
Environmental toxin exposure is thought to be associated with
the occurrence of urothelial cancer. However, this study presented
an independent role of RAPTOR genetic variation for susceptibility
of urothelial cancer. The predictive effect of RAPTOR genetic varia-
tion for urothelial cancer seems to be more important than
currently known environmental toxins in this validation study.
Research into raptor-mTOR complex interfering malignant trans-
formation of urothelium is worthy of further investigation.
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